Crossmark

Study protocol of the PIMPI-project, a cohort study on acceptance, tolerability and immunogenicity of second trimester maternal pertussis immunization in relation to term and preterm infants

Crossref DOI link: https://doi.org/10.1186/s12879-021-06559-w

Published Online: 2021-09-03

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Immink, Maarten M. http://orcid.org/0000-0001-9266-379X
Bekker, Mireille N.

de Melker, Hester E.

Rots, Nynke Y.

Sanders, Elisabeth A. M.

van der Maas, Nicoline A. T.
Funding

Funding for this research was provided by:

zonmw (522004008)
License Information

Text and Data Mining valid from 2021-09-03

Version of Record valid from 2021-09-03
More Information

Article History

Received: 4 August 2021

Accepted: 11 August 2021

First Online: 3 September 2021

Declarations

:

: This study was approved by the Central Committee on Research Involving Human Subjects in the Netherlands (Registration Number: NL66966.000.18). All participants provide written informed consent for participation.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below